ArticleOncoimmunology

Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.

Sheila López-Cobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.